Abstract. The effect of homocysteine (Hcy) on extracellular-superoxide dismutase (EC-SOD) methylation levels in the aorta of mice was observed and the underlying mechanism of THP-1 monocyte-derived macrophages was investigated. The key targets of Hcy-induced EC-SOD methylation changes were identified. ApoE -/-mice were fed different diets for 15 weeks and the concentrations of Hcy and lipids were subsequently detected using an automatic biochemistry analyzer. Serum levels of Hcy and lipids were significantly higher in the Meth group compared with the control group. EC-SOD and DNA methyltransferase (DNMT)1 mRNA and protein expression levels were detected by reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis, respectively. EC-SOD methylation levels were assessed using nested touchdown methylation-specific PCR (ntMS-PCR). Oxidative stress was measured using chromatometry. Recombined vectors overexpressing and silencing EC-SOD were transfected into macrophages. Following the transfection of macrophages with pEGFP-N1-DNMT1, the methylation levels of EC-SOD were detected. Furthermore, EC-SOD DNA methylation levels were significantly decreased in the Meth group. The promoter activity of EC-SOD was increased following transfection with -1/-1100 fragment and DNMT1 mRNA expression was significantly decreased in the Meth group. Following transfection with the recombinant plasmid, DNMT1 protein expression was significantly increased. ntMS-PCR results revealed that EC-SOD methylation levels significantly decreased in the Meth group, while they increased in N1-DNMT1 groups compared with the controls. In conclusion, Hcy may alter the DNA methylation status and DNMT1 acts as the essential enzyme in the methyl transfer process to disturb the status of EC-SOD DNA methylation, leads to a decrease in the expression of EC-SOD to promote oxidative stress and AS.
Introduction
Increased production of superoxide anions leads to oxidative stress, which has been implicated in a number of cardiovascular diseases, including atherosclerosis (AS), hypercholesterolemia, hypertension, diabetic cardiomyopathy, diabetic retinopathy and ischemic heart disease (1). Epidemiological evidence indicates that homocysteine (Hcy) is an independent risk factor for the development of AS (2) . Previous studies have demonstrated that Hcy may cause an imbalance between oxidation and oxidation resistance (3, 4) . However, it is not clear whether the development of AS is influenced by the association between Hcy and oxidative stress.
Oxidative stress is caused by an imbalance between the production of reactive oxygen and the body's ability to detoxify the reactive intermediates and repair the resulting damage (3) . Superoxide dismutases (SODs) are a major cellular defense against oxygen free radicals and the formation of peroxynitrite (5) . All mammalian tissues contain three forms of SOD; cytosolic (Cu/Zn-SOD), mitochondrial (Mn-SOD) and extracellular (EC-SOD) (6) . EC-SOD, a copper-and zinc-containing glycoprotein secreted from vascular smooth muscle cells, is the most abundant in vascular tissues and; however, in atherosclerotic vessels, EC-SOD is also generated by lipid-laden macrophages (7) . Several previous studies have indicated that EC-SOD is an important mediator for modulating vascular tone and inhibiting atherogenesis (8, 9 cholesterol levels have been reported in EC-SOD-null mice, as well as a high frequency of AS lesions and high interstitial concentrations of superoxide anions (10) . Mechanisms of oxidative stress-induced AS have been extensively studied in the past decade (11) ; however, the mechanisms, including the association between oxidative stress and Hcy, remain unclear.
Hwang et al (12) reported that Hcy promoted oxidative stress by downregulating the expression of EC-SOD in patients with AS. However, to the best of our knowledge there is no direct evidence explaining the mechanisms by which Hcy affects the expression of EC-SOD and disturbs the balance between oxidative-induced AS. Epidemiological studies have demonstrated that a mildly elevated plasma Hcy level is an independent risk factor for the development of AS (13) . Hcy is a non-protein, sulfur-containing amino acid, which is formed exclusively by the demethylation of methionine (14) . Hcy is a precursor of S-adenosylmethionine (SAM), the primary methyl group donor for most biological methylations, particularly DNA, which is a form of epigenetic gene regulation that functions in conjunction with the altered binding profiles of transcription factors (15) . Together, these modifications often lead to the suppression of gene expression when they occur in regulatory genomic regions, particularly in the promoter regions (16) . It has been previously reported that the fatty acid-binding protein gene becomes hypomethylated and the expression of mRNA increases in cultured macrophages and foam cells treated with Hcy (17) . In the cycle of a methyl transfer reaction, Hcy is remethylated to methionine, then S-adenosylhomocysteine (SAH) is released as a by-product and this cycle is maintained by DNA methyltransferases (DNMTs), including DNMT3 and DNMT1 (18) . The majority of research into DNA methylation is from developmental biology, cancer biology and studies with targeted deletions of mouse DNMT1, which is the 'maintenance' methyltransferase that ensures the correct transmission of the methylation profile from maternal to daughter cells during cell division (19) . In recent years, researchers have focused on the role of DNA methylation in AS, looking for a novel insight into the cause of AS and a better understanding of the epigenetic mechanisms underlying AS pathogenesis (20) . Laukkanen et al (21) investigated the methylation of CpG islands located on the coding sequence of the EC-SOD gene in the AS lesions of hyperlipidemic rabbits. However, the association between DNA methylation and EC-SOD expression has not been elucidated in detail, particularly the mechanisms by which DNA methylation regulates the expression of EC-SOD and disturbs the balance of oxidation and anti-oxidation, leading to AS.
Materials and methods

Animals and treatment protocols.
A total of 36 male ApoE -/-mice (6 weeks old; 25 g) were obtained from the Animal Center of Peking University Health Science Center (Beijing, China). They were housed individually in a climate-controlled room at 24˚C with 60% humidity. A total of 12 male C57BL/6J mice (6 weeks old; ~25 g; Animal Center of Peking University Health Science Center) were fed a regular mouse diet (Joint Feed Co. Ltd., Beijing, China) and were considered the normal control group (N-control). A total of 36 C57BL/6J ApoE -/-mice were divided into three groups (n=12/group) and maintained for 15 weeks on the following diets: ApoE -/-mice control group (A-control), fed with a regular mouse diet; Meth group, fed with a regular diet plus 1.7% methionine to establish a hyperhomocysteinemia (HHcy) model; Meth-F group, fed with regular diet plus 1.7% methionine (wt/wt), 0.006% folate and 0.0004% Vitamin B 12 (Weitonglihua, Ltd., Beijing, China). All mice had free access to food and water. The treatment of laboratory animals and the experimental protocol used followed the guidelines set out by the Ningxia Medical University (Yinchuan, China) and was approved by the Committee for Laboratory Animal Care. On the morning of the final day of the diet period, the mice in each group were anesthetized with 20% ethylcarbamate (1,000 mg/kg) by intraperitoneal injection, blood was collected by cardiac puncture and the mice were euthanized by exsanguination. The serum was separated by centrifugation (1,000 x g for 10 min at 4˚C) and all samples were stored at -80˚C prior to further analysis.
THP-1-derived macrophage culture. THP-1, a human monocytic cell line, was obtained from the American Type Culture Collection (Manassas, VA, USA) and the cells were grown in Roswell Park Memorial Institute 1640 medium with 15% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) with penicillin (100 units/ml) and streptomycin (100 µg/ml) at 37˚C in a 5% CO 2 atmosphere, to a density of 4x10 6 cells/ml. THP-1 cells were subsequently differentiated into macrophages by incubation with 500 µmol/l phorbol myristate acetate at 37˚C for 24 h. In the Hcy groups, cells were treated with 50, 100, 200 or 500 µmol/l Hcy for 72 h. In the antagon group, cells were treated with 100 µmol/l Hcy, 30 µmol/l folate and 30 µmol/l vitamin B 12 for 72 h.
Determination of serum Hcy (Hcy) and lipid levels in mice.
The concentrations of Hcy, total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were detected using an ADVIA ® 2400 Chemistry system (Siemens AG, Munich, Germany) by conventional enzymatic methodology (17) .
Superoxide anion detection. To evaluate the O 2
-production by the aorta and macrophages, the membrane permeable indicator dichlorofluorescin diacetate (H 2 DCF-DA) was used. The samples were combined with 10 µmol/l H 2 DCF-DA (JianCheng Biotech Co., Ltd., Nanjing, China) in serum-free Dulbecco's modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc.) at 37˚C for 30 min and subsequently washed twice with PBS. Following pre-incubation at 37˚C with atorvastatin (10 µmol/l; Honghui Bio-Pharmaceutical Co., Ltd., Beijing, China), N-acetyl-L-cysteine (NAC; 1 mmol/l) or 4' ,6-diamidino-2-phenylindole (DPI; 10 µmol/l) for 30 min, the samples were analyzed using a flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. Superoxide anion concentration was determined by comparing the changes in fluorescence intensity using a BD™ Cytometric Bead Array (CBA) FCAP Array Software v3.0 (BD Biosciences).
Tissue preparation and evaluation of AS lesions. Following cardiac puncture, the aorta was harvested, sampled, washed in distilled water, dipped in 78% methanol and stained for 40 min in 0.16% Oil-Red-O dissolved in 78% methanol/0.2 mol/l NaOH (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) at room temperature. For morphological analysis, 7 µm frozen sections were stained with hematoxylin and eosin (H&E) according to standard protocols. For quantification of the lesion area, serial cross sections of the aortic roots (7-µm-thick) and five serial sections were prepared from each location and conventionally stained with Oil-Red-O according to the method described by Yang et al (17) . The lesion areas were quantified by a single observer blinded to the experimental protocol. The stained plaque areas were quantified using Image Pro Plus software version 4.5 (Media Cybernetics, Inc., Rockville, MD, USA).
Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) for EC-SOD and DNMT1 mRNA expression in the aorta and macrophages. Total RNA was extracted from 80 mg aorta using TRIzol reagent according to the manufacturer's protocol (Invitrogen; Thermo Fisher Scientific, Inc.). RNA was reverse transcribed using a RevertAid™ First Strand cDNA Synthesis kit (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. A SYBR Green kit (Thermo Fisher Scientific, Inc.) was used for RT-qPCR analysis. The primer nucleotide sequences used are listed in Table I . The reaction steps were comprised of an initial activation step at 95˚C for 10 min, followed by a 2-step PCR program of 95˚C for 15 sec, annealing temperatures (Table I) for 30 sec and 60˚C for 30 sec for 45 cycles. An amplification curve was obtained for each qPCR run. The relative change in DNMT1 mRNA expression was determined by the fold change analysis (N) using the 2 -∆∆Cq , method (18) .
Immunofluorescence staining for EC-SOD in the aorta.
Immediately following excision, the aorta was fixed in 10% buffered formalin at room temperature for 48 h and embedded in paraffin. Serial sections (7-µm-thick) were prepared on glass slides for immunofluorescence staining. Unstained sections were dried at 60˚C overnight, deparaffinized and rehydrated for routine histologic staining procedures. Following antigen retrieval at 100˚C and washing twice in PBS for 3 min, the sections were incubated with 10% goat serum (Tianhang Biotechnology Co., Ltd. HangZhou, China) at 37˚C for 2 h to block non-specific binding and overlaid with a 1:50 dilution of goat anti-mouse antibodies directed against EC-SOD at 1:100 dilution (cat. no. ab80946, Abcam, Cambridge, UK) overnight at 4˚C. The following day the sections were washed with PBS and incubated with a 1:50 dilution of fluorescein isothiocyanate-conjugated rabbit anti-goat immunoglobulin (Ig) G secondary antibodies (cat. no. ab8227; Abcam) for 1 h at 37˚C, followed by washing in PBS three times and nuclear counterstaining with DAPI (BIOSS, Beijing, China) at 37˚C for 1 h. Bound antibodies were viewed under an Olympus BX51 microscope and images were captured (Olympus Corp., Tokyo, Japan; magnification, x100). Immunocytochemistry images were assessed using densitometry and analyzed using Image Pro-Plus 6.0 software (Media Cybernetics, Inc.). The OD value and area of intracellular brown staining in section were recorded.
EC-SOD promoter sequence analysis and reporter gene construction and promoter activity. Human EC-SOD gene 5'-flanking sequences were retrieved from The Eukaryotic
Promoter Database (epd.vital-it.ch). The core promoter of EC-SOD was analyzed by the Berkeley Drosophila Genome Project (fruitfly.org:9005/seq_tools/promoter.html) and MethPrimer (urogene.org/methprimer/index1.html). The EC-SOD promoter reporter gene assay was performed using a Dual-Luciferase ® reporter assay (Promega Corporation, Madison, WI, USA) according to the manufacturer's protocols. The EC-SOD 5'-flanking sequences were PCR-amplified from human macrophage genomic DNA using the primers listed in Table II . DNA was extracted from macrophages and PrimeSTAR ® Max DNA Polymerase (cat.no. R045A, Takara Bio, Inc., Otsu, Japan) was used for PCR. Primers are listed in Table II . Thermocycling conditions comprised a denaturation step at 94˚C for 30 sec, followed by 30 cycles of a primer annealing at 55˚C for 30 sec and synthesis of DNA for 1 min at 72˚C. These PCR products were fused to the firefly luciferase reporter vector pGL3-basic by EcoR I and Hand III digestion. When the macrophages grew to 80% confluence in a 12-well plastic dish they were transfected with 0.1 µg pGL3-basic or equimolar pGL3-ECSOD constructs using Lipofectamine ® 2000 reagent (Invitrogen, Thermo Fisher Scientific, Inc.) at 37˚C for 24 h. The Renilla luciferase expression vector phRL-TK (0.005 µg; Promega Corporation), whose activity is unaffected by homocysteine, was cotransfected as an internal control. Cell lysates were prepared for the luciferase assay using luciferin and a luminometer (Promega Corporation). Promoter activities were normalized to phRL-TK and expressed as fold increase over pGL3-basic.
Nested methylation specific (nMS)-semi quantitative PCR for EC-SOD methylation assay.
Genomic DNA was isolated from the aorta and macrophages using a Wizard ® Genomic DNA Purification kit (Promega Corporation). An integrated DNA denaturation and bisulfite conversion process was accomplished Table I . Primer sequences of ECSOD and DNMT 1 for real-time PCR analyses. in one step using an EZ DNA Methylation-Gold™ kit (Zymo Research Corp., Irvine, CA, USA). nMS-PCR consisted of two-step PCR amplification following a standard sodium bisulfite DNA modification. The first step used an outer primer pair that did not contain any CpG. The second-step PCR was carried out using the conventional PCR primers. A summary of the primers used and product sizes of the nMS-PCR assays are listed in Table III . To reduce mispriming and to increase efficiency, touchdown (TD) PCR was used in the amplification. Samples were subjected to 30 cycles in a TD program (94˚C for 30 sec, 69˚C for 30 sec and 72˚C for 1 min, followed by a 0.5˚C decrease in the annealing temperature every cycle; 20 cycles total). Following completion of the TD program, 20 cycles were run (94˚C for 45 sec, 54˚C for 45 sec and 72˚C for 45 sec), ending with a 5 min extension at 72˚C. The PCR products were separated by electrophoresis on a 2% agarose gel containing ethidium bromide. The DNA bands were visualized by ultraviolet and quantified using a Gel Documentation and Analysis System ChemiDoc XRS system with Image Lab software, version 4.1 (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Relative methylation was calculated using the following formula: Methylation=methylation/(methylation+u nmethylation) x100.
Determination of aortic SAM and SAH concentrations. SAM and SAH were determined using high performance liquid chromatography (HPLC). The aortic tissues (20 mg) were homogenized, mixed thoroughly in a 1 ml 20% HClO 4 solution and samples were loaded onto a C18 column (Shimadzu Corporation, Kyoto, Japan) and run by a Hitachi L2000 HPLC system (Hitachi, Ltd., Tokyo, Japan). SAM and SAH standards were used to identify the elution peaks, chormatograms were recorded and the SAM and SAH values of the tissues were calculated based on the standard curve (18) .
Gene recombination and short interfering (si)RNA knockdown of EC-SOD and DNMTI.
The human EC-SOD/DNMT1 gene fragment was extracted from macrophages and amplified by PCR. DNA was extracted from macrophages and PrimeSTAR ® Max DNA Polymerase (cat.no. R045A, Takara Biomedical Technology Co., Ltd.) was used for PCR. Primers are listed in Table IV . Thermocycling conditions comprised a denaturation step at 94˚C for 30 sec, followed by 30 cycles of a primer annealing step at 58˚C for 30 sec and synthesis of DNA for 1 min at 72˚C. The vectors and the purified PCR fragments were digested by EcoRI and HindIII (Fermentas; Thermo Fisher Scientific, Inc.). The plasmid was cleaved by the were prepared and added to each well of a 96-well plate. The fluorescence intensity was used to identify the transfection efficiency using an inverted fluorescence phase contrast microscope (Olympus IX71; Olympus Corp.; magnification, x100). The transfected cells were treated with Hcy. Following 24 h, the activity of EC-SOD/DNMT1 was detected by PCR. Western blotting was performed to examine the fusion gene expression.
siRNA of EC-SOD and DNMT1 were supplied by Invitrogen (Thermo Fisher Scientific, Inc.). Macrophages were transfected when they reached 80-90% confluence. For each sample, complexes of siRNA molecule-Lipofectamine 2000 were prepared and added to 96-well plates. Detection of fluorescence intensity was performed using a fluorescence microscope and it was used to identify the transfection efficiency. The transfected macrophages were treated with 100 µmol/l Hcy at 37˚C for 24 h and the activity of EC-SOD was determined by qPCR. Western blotting was performed to examine the fusion gene expression using antibodies against EC-SOD (cat. no. sc-271170, Santa Cruz Biotechnology, Inc., Dallas, TX, USA).
Western blot analysis for EC-SOD in macrophages.
Total proteins were isolated from the cells using cell lysis buffer (Keygen Biotech Co., Ltd., Nanjing, China) and proteins were quantified using a bicinchoninic acid protein assay kit. Equal amounts of protein (80 µg) were separated by 12% SDS-PAGE and transferred onto polyvinylidene fluoride membranes. Membranes were subsequently blocked in 5% skimmed milk for 2 h at room temperature with gentle agitation on a platform shaker. Membranes were incubated with antibodies against EC-SOD (1:500) and β-actin (cat. no. sc-70319, Santa Cruz Biotechnology, Inc.; 1:2,000) at 4˚C overnight. A secondary goat anti-mouse immunoglobulin G-horseradish peroxidase antibody (cat.no. sc-2031; 1:2,000; Santa Cruz Biotechnology, Inc.) was added for 2 h at room temperature. The protein bands were visualized and analyzed using a Gel Documentation and Analysis System ChemiDoc XRS system with Image Lab software, version 4.1 (Bio-Rad Laboratories, Inc.).
Statistics.
Results are expressed as the mean + standard error of mean. The data were analyzed using one-way analysis of variance and additional analysis was done using the Student-Newman-Keuls test for multiple comparisons within groups or a t-test for the comparison of two groups. Correlation analysis was performed using Pearson's correlation analysis. P<0.05 was considered to indicate a statistically significant difference.
Results
Serum Hcy and serum lipid levels are altered in mice.
To verify whether a hyperhomocysteinemia (HHcy) model was successfully established, mouse serum Hcy and lipids were analyzed. The concentrations of Hcy Furthermore, TG and LDL levels increased in ApoE -/-mice fed with a high-methionine diet, but TG and LDL concentrations were decreased when mice were feed folate and vitamin B12 (Fig. 1B) . TC increased when ApoE -/-mice were fed with a high-methionine diet and this was reversed when mice were fed with folate and vitamin B 12 (Fig. 1C) . HDL concentrations were decreased in the high-methionine diet groups and increased after mice were fed with folate and vitamin B 12 diet (Fig. 1D) . These results suggest that a high methionine diet may induce HHcy in ApoE -/-mice, while folate and Vitamin B 12 are able to ameliorate the effects of HHcy.
HHcy promotes AS lesions in ApoE
-/-mice. To confirm the atherogenic effects of HHcy, AS lesions were examined by H&E ( Fig. 2A) and Oil Red O staining (Fig. 2B) . The lesion area was measured using Image Pro Plus software. The area of AS lesions was significantly increased in the A-control (Fig. 2C) . However, compared with the Meth group, the AS lesion area in the Meth-F group was significantly decreased 45.2% (P<0.05), which suggests that folate and vitamin B 12 may modulate the effect of a high methionine diet. Compared with the N-control group, the number of AS lesion areas significantly increased by 1.41, 2.58 and 1.41-fold in the A-control (P<0.05), Meth (P<0.05) and Meth-F (P<0.01) groups, respectively. The atherosclerotic lesion areas were positively correlated with the levels of serum Hcy (r=0.6862; P<0.0001; Fig. 2D ).
Elevated superoxide anion promotes the formation of AS lesions induced by HHcy.
Oxidative stress serves a critical role in the occurrence and development of AS (14) . Reactive oxygen species (ROS) and their reaction products are important mediators in vascular pathology and oxidative stress, particularly superoxide anions. The results of the present study demonstrated that, compared with the N-control group, the inhibiting rate of superoxide anions increased after ApoE -/-mice were fed with high-methionine diet (Fig. 3A) . The activity of superoxide anions in the Meth-F group decreased by 15.5% compared with the Meth group (P<0.05). The AS lesion areas were positively correlated with the levels of superoxide anions (r=0.2304; P=0.0239; Fig. 3B ), indicating that superoxide anions may enhance the development of AS lesions.
Hcy decreases EC-SOD expression in the aorta of ApoE
-/-mice. It has been reported that EC-SOD is bound to the extracellular matrix and constitutes an important defense mechanism against superoxide anions in the arterial microenvironment (22) . To confirm the role of EC-SOD in the atherogenic effects of HHcy, qPCR and western blot analysis were performed to detect EC-SOD expression in the aorta. Levels of EC-SOD mRNA were significantly decreased in the Meth group compared with the N-and A-control groups (P<0.01 and P<0.05, respectively; Fig. 4A) ; however, the Meth-F group had significantly increased levels of EC-SOD mRNA compared with the Meth group (P<0.05). The level of EC-SOD protein expressed was significantly reduced in the Meth group compared with the N-control (P<0.01; Fig. 4B) ; however, it was significantly increased in the Meth-F group compared with the Meth group (P<0.05). This suggests that Hcy suppresses the production of EC-SOD protein, while folate and vitamin B 12 are able to reverse this effect. These results indicate the same thing as immunofluorescent staining and they suggest that EC-SOD is associated with the pathological process of HHcy-induced AS in ApoE -/-mice.
EC-SOD expression is suppressed by Hcy in macrophages.
To confirm the Hcy-induced expression of EC-SOD in macrophages, EC-SOD mRNA by was detected by RT-PCR (Fig. 5A ) and protein expression was quantified by western blot analysis (Fig. 5B) following incubation of the macrophages with varying concentrations of Hcy (50-500 µmol/l) for 72 h. EC-SOD mRNA expression was significantly decreased after Hcy was administered at 50 (P<0.05), 100, 200 and 500 µmol/l (all P<0.01) compared with the control group. Furthermore, EC-SOD mRNA expression was mediated by folate and vitamin B 12 . EC-SOD protein expression was significantly suppressed in the Hcy groups. In the antagon group the protein expression significantly increased by 1.6-fold, compared with the 100 µmol/l group (P<0.05). These results suggest that EC-SOD is regulated by Hcy in macrophages and that it may be associated with the macrophage response to oxidative stress, as SOD is known to be essential for eliminating oxidization (23) . Folate and vitamin B 12 protected the cells from oxidative damage caused by the toxicity of Hcy.
Analysis of EC-SOD promoter activity.
The EC-SOD -1/-1100 fragment, which spans the largest number of CpG dinucleotides performed the highest promoter activity (Fig. 6) . The 200-bp (-200/-1), 1400-bp (-1400/-1) and 700-bp (-700/-1) fragments expressed similar but modest promoter activity, while the 2000-bp (-2000/-1) fragment had minimal activity. The treatment results revealed that the activity of the EC-SOD promoter depends on the different fragments, which vary in the number of CpG sites they contain. As observed in Fig. 6 , five fragments were detected to determine which fragment serves a dominant role in the DNA methylation of the promoter. Compared with pGL3-basic, the luciferase activity in the -1/-2000, -1/-1400 and -1/-200 fragment groups were significantly increased by 2.0-, 3.54-and 3.38-fold, respectively (P<0.05). The -1/-1100 fragment group increased by 7.15-fold compared with the pGL3-basic group, which was the greatest increase (P<0.001). These results indicate that the levels of EC-SOD methylation change principally due to existing sensitive sites in the promoter region.
EC-SOD hypomethylation in the aorta of ApoE
-/-mice induced by Hcy. The DNA methylation pattern is considered to be a useful molecular marker of AS due to its role in silencing DNA transcription (24) . The present study confirmed the activity of the EC-SOD promoter and the results imply that EC-SOD may be regulated by promoter methylation. DNA methylation of EC-SOD was analyzed to elucidate the cause of EC-SOD expression changes. It was revealed that EC-SOD methylation was decreased by 14.6% (P<0.05) in the Meth group compared with the N-control group (Fig. 7) . These results indicate that Hcy suppresses EC-SOD DNA methylation, then resulting in reduced EC-SOD transcription in the aorta.
The mechanisms of EC-SOD hypomethylation in the aorta of ApoE
-/-mice induced by HHcy. It has previously been reported that Hcy has an effect on the activity of DNA methyltransferases, which are associated with DNA methylation (25) . To further explore the role of DNMT1 in HHcy-induced EC-SOD hypomethylation, mRNA expression of DNMT1 in the aorta was examined. The DNMT1 mRNA levels were significantly increased in the Meth group, where the mice were fed a high-methionine diet (P<0.01; Fig 8A) suggesting that DNMT1 serves a crucial role in EC-SOD DNA hypomethylation induced by HHcy.
SAM is an important intermediate in the transmethylation reaction, while SAH is a potent inhibitor of cellular transmethylation (18) . To illustrate the mechanism of HHcy mediated EC-SOD DNA methylation in ApoE -/-mice, analyses of SAM and SAH were performed by HPLC (Fig. 8B) . In the Meth Figure 6 . Analysis of EC-SOD promoter activity. Different lengths of human EC-SOD 5'-flanking sequences were fused to the luciferase gene in a pGL-3.1. The fragments of promoter activity were subsequently analyzed by calculating the ratio of luminescence from the experimental reporter vector to the luminescence from a control vector (phRL-TK). The promoter fragments were co-transfected with the phRL-TK control into macrophages for 24 h prior to the measurements being taken. * P<0.05 and ** P<0.01 vs. the pGL3-basic group. n=3/group. pGL-3.1, pGL3-basic vector; EC-SOD, extracellular-superoxide dismutase. group the concentrations of SAM and SAH were significantly increased by 2.8-and 1.78-fold, respectively,, compared with the N-control group (P<0.01). The concentrations of SAM and SAH were significantly decreased by 52.7 and 38.5% in the Meth-F group compared with the Meth group (P<0.01). These results indicate that SAM and SAH may exert regulatory effects on DNA methylation.
EC-SOD serves a major role in resistance to oxidative stress in macrophages induced by Hcy.
To verify the role of EC-SOD in resistance to HHcy-induced oxidative stress, the recombined vector pcDNA3.1-ECSOD was constructed and transfected into macrophages using Lipofectamine 2000. Observation of green fluorescence verified that the recombined vector had been successfully transfected into the macrophages (Fig. 9A) . Subsequently, the levels of EC-SOD mRNA was significantly increased in the pcDNA3.1-ECSOD transfected group compared with the pcDNA3.1 transfected group and the control (both P<0.01; Fig. 9B ). EC-SOD protein levels were significantly increased in the pcDNA3.1-ECSOD group (Fig. 9C) . The expression of EC-SOD was silenced by siRNA fragments to confirm the role of EC-SOD on Hcy-induced oxidative stress in macrophages. EC-SOD mRNA expression was significantly decreased after cells were transfected with the -247 and -596 fragments (Fig. 9D) . Meanwhile, EC-SOD protein levels were analyzed using western blotting and demonstrated to be decreased (Fig. 9E) . The results indicate that the -596 fragment was the most effective RNA interference fragment, so it was selected for further research.
The superoxide anion content was measured by chromatometry following transfecting the recombined vector and the -596 RNA interference fragment for EC-SOD (Fig. 9F) . The superoxide anion content was increased significantly by 1.88-and 2.4-fold in the Hcy (P<0.05) and S3+Hcy (P<0.01) groups. Conversely, the superoxide anion content was decreased significantly with EC-SOD overexpression and Hcy treatment (P<0.05). Taken together, these results suggest that EC-SOD served a major role in oxidative stress in macrophages induced by Hcy.
DNMT1 serves a key role in EC-SOD hypomethylation in macrophages.
The transfection efficiency of the recombination vector EGFP-N1-DNMT1 was measured by fluorescence microscopy (Fig. 10A) . The observed green fluorescence verified that the recombination vector has been successfully transfected into the macrophages. Subsequently, DNMT1 levels were detected by RT-PCR and western blot analysis (Fig. 10B) . The DNMT1 protein expression and mRNA levels were significantly increased following recombination with N1-DNMT1. The impact of over-expression of DNMT1 on the EC-SOD methylation level was investigated (Fig. 10C) . EC-SOD methylation levels were increased significantly by 1.6-fold in the EGFP-N1-DNMT1 group compared with the control (P<0.01). These results support the hypothesis that Hcy-induced DNMT1 inhibition mediates the demethylation of the EC-SOD promoter.
Discussion
Previous studies have suggested that an increased concentration of plasma Hcy accelerates the progression of AS and promotes atherothrombotic events (26, 27) . In the present study it was revealed that serum Hcy and plasma lipid concentrations were significantly elevated and AS lesion areas were significantly expanded in ApoE -/-mice fed a high methionine diet. Furthermore, the activity of superoxide anion was increased in the aorta of these mice. The results demonstrate that the contents of Hcy and superoxide anion were increased in ApoE -/-mice. Vaidya et al (28) also revealed that oxidative stress was increased in the AS vessel walls in patients exhibiting HHcy. These results indicate that Hcy-induced AS may occur due to the imbalance of oxidative stress.
Oxidative stress is regulated by a variety of redox enzymes and antioxidants (29) . Antioxidants occur naturally within mammalian tissues where they protect against the harmful side effects of ROS by counteracting free radical reactions (30) . At present, the antioxidant enzyme EC-SOD is considered to be responsible for defending the body against oxygen free radicals, eliminating superoxide anions by converting them to O 2 and hydrogen peroxide (31) . It was also revealed that the expression of EC-SOD increases in the AS vessels of ApoE -/-mice and in macrophages treated with Hcy, in association with the levels of EC-SOD protein. The lipid-laden macrophage is considered an important component of the human atheroma, it has been reported that EC-SOD expression in macrophages may be important in certain human diseases (32) . The aim of the present study was to demonstrate whether EC-SOD is a vital factor in the body's defense against the superoxide anion. It was revealed that the concentration of superoxide anion decreased following transfection with recombined pCDNA3.1-ECSOD, whereas the superoxide anion was increased when EC-SOD siRNA fragments were transfected into macrophages. This suggests that EC-SOD is a key factor in eliminating ROS.
DNA methylation is an important epigenetic mechanism that selectively regulates gene expression and is associated with cardiovascular disease. Lund and Zaina (33) reported that specific changes in the DNA methylation pattern occur prior to the appearance of vascular lesions in ApoE -/-mice, particularly in the aorta and circulating inflammatory cells, including macrophages. They also demonstrated that alterations in DNA methylation profiles are early markers of AS in mouse models and may have a causative role in AS (34) . In the present study, it was revealed that EC-SOD DNA methylation was increased in macrophage cells and in the AS lesions of ApoE -/-mice. It has been reported that DNA hypomethylation is associated with changes in gene expression during the development of AS lesions (35) . Compared with gene regulatory elements, epigenetic modifications are able to change and respond to physical and biological signals. The analysis of promoter activity provided a novel insight into which sites within the promoter region were responsible for the status of DNA methylation. The activity of the EC-SOD promoter, the expression of DNMT1 and concentrations of SAM and SAH, were detected in the present study to investigate the mechanism of EC-SOD DNA hypomethylation induced by Hcy. In the present study, it was observed that the -1100/-1 fragment with a larger number of CpG islands in the EC-SOD promoter region had the highest activity. CpG islands are potential sites of methylation and this may explain the regular occurrence of mutations and the methylation status of each of the CpG dimers located within the coding sequence when characterized using direct genomic sequencing. Rhee et al (36) revealed that a marked reduction in the number of methylated CpG dinucleotides in the EC-SOD gene were detected in AS aortas compared with normal aortic intima-media. A number of previous studies have reported that Hcy is regulated by the expression of DNMTs, particularly DNMT1 (13, 37) . In the process of methyl transfer reactions, methionine is converted to Hcy with SAM and SAH as byproducts. As the only methyl group donor, SAM is catalyzed by DNMT1 and converted to SAH (38) . In a previous study by the authors, it was revealed that Hcy promoted the expression of DNMT1 via hypomethylation of genes associated with AS (18) . In the present study, DNMT1 expression was decreased in macrophage cells treated with Hcy and in the AS lesions of ApoE -/-mice, in accordance with the hypomethylation of EC-SOD. As a critical enzyme in the SAM methyl transfer process, elevated DNMT1 may lead to an increase in EC-SOD DNA methylation.
As SAM is the major methyl group donor, while SAH is a potent inhibitor of the cellular transmethylation reaction, a reasonable deduction is that hypomethylation is a passive process due to the increase of SAM and the SAM/SAH ratio and the decline of SAH (39) . As Hcy promoted the expression of DNMT1, this caused the transmethylation reaction to slow and the concentration of SAM and SAH increased, as well as the ratio of SAM/SAH. In the present study, it was revealed that there was an increase in the concentration of SAM and the ratio of SAM/SAH in the aorta of ApoE -/-mice. This observation is associated with the hypothesis that SAM and SAH are key components in the pathophysiology of the Hcy-vascular disease axis.
The present study demonstrates that vitamin B 12 and folate may relieve the effect of methylation in cultured macrophages treated with Hcy. It was also revealed that vitamin B 12 and folate relieved the injury of AS lesions. Hcy may either be remethylated to methionine (requiring folate and vitamin B 12 ) or converted to cysteine in the trans-sulfuration pathway (requiring vitamin B 12 ) (40) . The re-methylation process requires two key enzymes; methionine synthase (using methylcobalamin as a coenzyme) and methylene tetrahydrofolate reductase, with 5-methyltetrahydrofolate as the methyl donor (41) . Therefore, the addition of vitamin B 12 and folate may influence the metabolism of Hcy and disturb the methylation and expression of EC-SOD.
In conclusion, the results of the present study indicate that Hcy may induce DNMT1 upregulation and EC-SOD DNA hypomethylation and this may be a major mechanism by which Hcy induces AS. These may present important novel mechanisms by which Hcy induces an imbalance of oxidative and anti-oxidative effects. This imbalance may contribute to the development of AS. Additionally, an increased folate and vitamin B 12 intake may be beneficial for the prevention of atherogenic diseases.
